Healthequity Fundamentals

HQY -  USA Stock  

USD 59.23  0.22  0.37%

Healthequity fundamentals help investors to digest information that contributes to Healthequity's financial success or failures. It also enables traders to predict the movement of Healthequity Stock. This fundamental analysis module provides a way for investors to measures Healthequity's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthequity stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Refresh
Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 286.41 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022.

Healthequity EBITDA Analysis

Healthequity's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Healthequity Earnings Before Interest Taxes and Depreciation Amortization EBITDA

95.14 Million

Share
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current Healthequity EBITDA

    
  177.76 M  
Most of Healthequity's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthequity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Healthequity EBITDA Historical Pattern

Today, most investors in Healthequity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Healthequity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Healthequity ebitda as a starting point in their analysis.
 Healthequity EBITDA 
Share
      Timeline 
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

Healthequity EBITDA Margin

EBITDA Margin

0.14

Share
Healthequity EBITDA Margin is fairly stable at the moment as compared to the past year. Healthequity reported EBITDA Margin of 0.14 in 2021
According to the company disclosure, Healthequity reported earnings before interest,tax, depreciation and amortization of 177.76 M. This is 79.74% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The ebitda for all United States stocks is 95.44% higher than that of the company.

Healthequity Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Healthequity's current stock value. Our valuation model uses many indicators to compare Healthequity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healthequity competition to find correlations between indicators driving Healthequity's intrinsic value. More Info.
Healthequity is rated # 2 in profit margin category among related companies. It is one of the top stocks in book value per share category among related companies . Healthequity Profit Margin is fairly stable at the moment as compared to the past year. Healthequity reported Profit Margin of -0.06 in 2021. Comparative valuation analysis is a catch-all model that can be used if you cannot value Healthequity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Healthequity's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healthequity's earnings, one of the primary drivers of an investment's value.

Healthequity Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthequity's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthequity could also be used in its relative valuation, which is a method of valuing Healthequity by comparing valuation metrics of similar companies.
Healthequity is currently under evaluation in z score category among related companies.

Healthequity Current Valuation Drivers

We derive many important indicators used in calculating different scores of Healthequity from analyzing Healthequity's financial statements. These drivers represent accounts that assess Healthequity's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Healthequity's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee46.12 K64.77 K13.53 K2.9 K2.61 K2.68 K
Revenue Per Employee223.49 K251.75 K181.51 K240.73 K216.65 K201.18 K
Average Assets339.77 M465.09 M1.7 B2.65 B3.13 B3.38 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings Before Interest Taxes and Depreciation Amortization USD68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings before Tax52.19 M75.82 M43.16 M4.14 M(66.74 M)(68.5 M)
Average Equity321.87 M440.87 M898.6 M1.28 B1.86 B2.01 B
Enterprise Value2.89 B3.6 B5.82 B7.22 B4.83 B4.65 B
Free Cash Flow65.86 M99.58 M72.07 M117.03 M69.38 M65.61 M
Invested Capital60.91 M35.17 M1.41 B1.16 B1.12 B1.21 B
Invested Capital Average65.25 M73.75 M804.95 M1.26 B1.14 B1.23 B
Market Capitalization3.07 B3.89 B4.68 B6.43 B4.47 B4.35 B
Tangible Asset Value280.87 M425.7 M449.07 M616.21 M488.13 M418.34 M
Working Capital244.91 M365.62 M145.36 M255.48 M198.15 M200.56 M

Healthequity Institutional Holders

Institutional Holdings refers to the ownership stake in Healthequity that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Healthequity's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Healthequity's value.
Security TypeSharesValue
Blackrock IncCommon Shares9.4 M635.5 M
Vanguard Group IncCommon SharesM539.4 M
Wasatch Advisors IncCommon Shares7.6 M515.2 M
Fmr LlcCommon Shares3.2 M216.9 M
William Blair Investment Management LlcCommon Shares3.1 M209.9 M
Jpmorgan Chase CoCommon Shares2.7 M180 M
State Street CorpCommon Shares2.6 M178.2 M

Healthequity Fundamentals

About Healthequity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Healthequity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthequity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthequity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Cost of Revenue332.9 M359.1 M
Revenues756.6 M816.3 M
Revenue to Assets 0.31  0.32 
Revenue Per Employee216.7 K201.2 K
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Healthequity Piotroski F Score and Healthequity Altman Z Score analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.